Psilocybin Research - Psilocybe mushroom research - Psychedelics research
A New Dawn?
After decades of stagnant research (see below), are we entering a new dawn?
While searching the web it occurred to me that the number of publications dealing with psilocybin and other psychedelics is increasing. I easily ran into psilocybin related research at the Maps.org web site: Johns Hopkins Study of Psilocybin in Cancer Patients * A Pilot Study of Psilocybin-Facilitated Addiction Treatment * Psilocybin Effects on Attention, Perception and Cognition * Experimental Studies on the Effects of Psilocybin on Binocular Depth Inversion, Binocular Rivalry ... That made me decide to add a new research section to magic-mushrooms.net.
In 1970, the Controlled Substances Act came into force, creating the five drug Schedules in place today: substances in Schedules I and II require a special license from the FDA too posses or use in experiment. Schedule I is the most restrictive category, with drugs in it defined as having no medical use and as being unsafe to use, even under medical supervision, with a high potential for abuse. The other schedules are less stringent; Schedule II drugs are still dangerous drugs with the potential for abuse but with some medical applications. Schedule III drugs have moderate potential for abuse and are considered safe under medical supervision. The government bodies that control aspects of drug scheduling and research are the DEA (Drug Enforcement Agency) and the FDA. The DEA controls which drugs are scheduled, and who has the right to possess and manufacture such drugs, and gives licenses to researchers. Researchers of all kinds of drugs, not just scheduled ones, must submit their experimental design and protocol to the FDA for approval. .... However the end result was the complete halting of research, responsible or irresponsible, when the FDA gained control over investigational drugs. ..... Although the crackdown and subsequent moratorium on human psychedelics studies was due to social considerations, many of the studies at the time were far from perfect. Although high rates of success were claimed by therapists in both of the different schools of LSD therapy, few long term studies were done to check that the results were permanent. Also, effect of “set and setting” mentioned above, although known, was hardly ever mentioned in clinical reports. Since these factors are extremely influential on the outcome of the experiment, there is little wonder that results were difficult to replicate: everyone was conducting their studies under widely different conditions.
Newspaper piece about Robin Carhart-Harris, a post-doc in neuroscience at Imperial College London. .... since the brain area affected by psilocybin can also be out of whack in mental health problems such as depression, the researchers speculate that the drug may turn out to be useful in treating mental illness..
..single high dose of the hallucinogen psilocybin, the active ingredient in so-called "magic mushrooms" was enough to bring about a measureable personality change lasting at least a year in nearly 60 percent of the 51 participants in a new study..
...new reason to hope for those suffering with a family member who has Conservative Disorder....The solution is a fungus used in religion and mysticism for thousands of years—the Psilocybin mushroom....